Skip to main content

Table 1 Comparison between MRSA and MSSA isolates regarding characteristics of patients, biofilm production ability and antibiotic resistance

From: Ability of biofilm production and molecular analysis of spa and ica genes among clinical isolates of methicillin-resistant Staphylococcus aureus

Factors

MRSAa, N (%)

MSSAb, N (%)

P-valuec

Age

 0–25

3 (12.5)

33 (27.0)

0.33

 26–50

9 (37.5)

35 (28.7)

 

 51–84

12 (50.0)

54 (44.3)

 

Sex

 Male

13 (54.2)

51 (41.8)

0.08

 Female

11 (45.8)

71 (58.2)

 

Clinical specimens

 Burn wound

15 (62.4)

41 (33.6)

0.12

 Diabetic wound

0 (0.0)

5 (4.1)

 

 Traumatic wounds

0 (0.0)

6 (4.9)

 

 Eye

6 (25.0)

43 (35.2)

 

 Urine

0 (0.0)

9 (7.4)

 

 Blood

1 (4.2)

2 (1.7)

 

 Brain abscess

1 (4.2)

4 (3.3)

 

 Respiratory tract

1 (4.2)

10 (8.2)

 

 Other

2 (1.6)

 

Hospitals

 Kashan

  

0.001

  Shahid Beheshti

3 (12.5)

49 (40.2)

 

 Isfahan

  Imam Musa Kazem (Burns hospital)

15(62.5)

41(33.6)

 

  Al-Zahra

2(8.3)

29(23.7)

 

  Amin

4(16.7)

3(2.5)

 

Wards

 Burns

15(62.5)

41(33.6)

0.09

 Infectious diseases

14(11.5)

 

 Emergency

7(29.2)

47(38.5)

 

 ICUd

2(8.3)

11(9.0)

 

 Outpatients

9(7.4)

 

Biofilm production ability

 Strong

21 (87.5)

90 (73.7)

0.43

 Moderate

1 (4.2)

5 (4.1)

 

 Weak

1 (4.2)

18 (14.8)

 

 Non-biofilm producers

1 (4.2)

9 (7.4)

 

Antibiotic resistance

 MDRe

20 (83.3)

32 (26.2)

0.001

 Non-MDR

4 (16.7)

90 (73.8)

 

Total

24

122

 
  1. aMethicillin-resistant Staphylococcus aureus
  2. bMethicillin-susceptible Staphylococcus aureus
  3. cP< 0.05 is significant
  4. dIntensive care unit
  5. eMultiple-drug resistance